George Llado's most recent trade in Charles River Laboratories International Inc. was a trade of 2,076 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 2,076 | 2,076 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 134.98 per share. | 21 May 2025 | 946 | 4,295 (0%) | 0% | 135.0 | 127,691 | Common Stock |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 134.98 per share. | 21 May 2025 | 519 | 4,814 (0%) | 0% | 135.0 | 70,055 | Common Stock |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,311 | 1,311 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 228.41 per share. | 13 May 2024 | 559 | 3,043 (0%) | 0% | 228.4 | 127,681 | Common Stock |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 228.41 per share. | 13 May 2024 | 306 | 3,349 (0%) | 0% | 228.4 | 69,893 | Common Stock |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 1,669 | 1,669 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 664 | 2,484 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 1,582 | 1,582 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 575 | 1,528 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 292 | 1,820 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,151 | 1,151 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 355 | 778 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 175 | 953 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 991 | 991 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 305 | 305 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | George Llado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 118 | 423 (0%) | 0% | 0 | Common Stock |